Catalyst Wire Dossier Catalyst Wire Dossier

JDB0131 Benzenesulfonate Tablets

JDB0131 benzenesulfonate · WestVac Biopharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JDB0131 Benzenesulfonate Tablets, covering 2024-01-25 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets [Phase 2]

See pricing